| scholarly article | Q13442814 |
| P50 | author | Andrew Allen | Q42946271 |
| Margaret J Morris | Q57659168 | ||
| Joohyung Lee | Q60954792 | ||
| P2093 | author name string | Barrett GL | |
| Murphy M | |||
| Mendelsohn FA | |||
| Chai SY | |||
| Albiston AL | |||
| McDowall SG | |||
| Ping SE | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 341-349 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats | |
| P478 | volume | 124 |
| Q26861984 | A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases |
| Q37336892 | Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy |
| Q34103606 | Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation |
| Q36923103 | Angiotensin IV upregulates the activity of protein phosphatase 1α in Neura-2A cells |
| Q37045324 | Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets |
| Q29347068 | Assessment of biological activity of novel peptide analogues of angiotensin IV. |
| Q35894732 | Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density |
| Q90631772 | Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study |
| Q37091405 | Central administration of angiotensin IV rapidly enhances novel object recognition among mice |
| Q51768228 | Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶. |
| Q42555106 | Crystal structure of human insulin-regulated aminopeptidase with specificity for cyclic peptides. |
| Q33393907 | Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase |
| Q34543485 | Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. |
| Q28579048 | Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system |
| Q89477194 | Effect of Endoplasmic Reticular Stress on Free Hemoglobin Metabolism and Liver Injury |
| Q33667232 | Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension |
| Q30530935 | Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents |
| Q24635261 | Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs |
| Q33682344 | Hemoglobin-derived Peptides as Novel Type of Bioactive Signaling Molecules |
| Q35210016 | Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers |
| Q39975532 | Identification of modulating residues defining the catalytic cleft of insulin-regulated aminopeptidase |
| Q51976616 | Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain. |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q36996248 | Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review |
| Q90703205 | Molecular insights into the interaction of hemorphin and its targets |
| Q38217456 | Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors |
| Q38781022 | Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy |
| Q36400573 | Small-molecule AT2 receptor agonists |
| Q61785672 | Structural Basis of Inhibition of Human Insulin-Regulated Aminopeptidase (IRAP) by Aryl Sulfonamides |
| Q37363586 | The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease |
| Q38005611 | The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases |
| Q35043146 | The likelihood of cognitive enhancement |
| Q44348916 | The opioid haemorphin-7 in horses during low-speed and high-speed treadmill exercise to fatigue |
| Q33217815 | The renin-angiotensin system: current data |
| Q30444206 | Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. |
Search more.